Page 10 - Read Online
P. 10
59 Role of the contrast-enhanced ultrasoud in the diagnosis of HCC in cirrhotic liver
Francesco Loria, Antonello Parlati, Giuseppe Loria, Luciano Frosina, Giuseppe Crea, Salvatore Basile,
Caterina Alessio, Giuseppe Di Leo, Adele De Caridi, Vittorio Maschio, Nicola Zizzi, Orazio
Trapuzzano, Salvatore Giuseppe Galea
Hepatoma Res 2018;4:59 http://dx.doi.org/10.20517/2394-5079.2018.75
60 Liver transplantation for hepatocellular carcinoma - non-cancer factors and implications for
improving outcome beyond standard tumor criteria
Arno Kornberg, Martina Schernhammer
Hepatoma Res 2018;4:60 http://dx.doi.org/10.20517/2394-5079.2018.86
61 Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through
alternative splicing of FIR (PUF60)/FIRΔexon2
Kazuyuki Matsushita, Tyuji Hoshino
Hepatoma Res 2018;4:61 http://dx.doi.org/10.20517/2394-5079.2018.81
62 Quantitative hepatitis B surface antigen in predicting recurrence of hepatitis B-related
hepatocellular carcinoma after liver transplantation
James Fung, Danny Ka-Ho Wong, Yasuhito Tanaka, Regina Lo, Tiffany Wong, Kenneth Siu-Ho Chok,
Albert Chi-Yan Chan, Tan-To Cheung, Wing-Chiu Dai, Kelvin Ng, Kevin Ng, Man Kwan, Irene Ng,
Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen, Chung-Mau Lo
Hepatoma Res 2018;4:62 http://dx.doi.org/10.20517/2394-5079.2018.92
63 Alpha-fetoprotein as a predictor of hepatocellular carcinoma recurrence following liver
transplantation
Evangelia M. Fatourou, Abid R. Suddle, Michael A. Heneghan
Hepatoma Res 2018;4:63 http://dx.doi.org/10.20517/2394-5079.2018.62
64 HCV elimination: breaking down the barriers to prison based care
Timothy Papaluca, Alexander Thompson
Hepatoma Res 2018;4:64 http://dx.doi.org/10.20517/2394-5079.2018.53
65 New and old biomarkers of hepatocellular carcinoma
Georgios Zacharakis, Ahmad Aleid, Khaled K Aldossari
Hepatoma Res 2018;4:65 http://dx.doi.org/10.20517/2394-5079.2018.76
66 Gender differences in hepatocellular cancer: disparities in nonalcoholic fatty liver disease/
steatohepatitis and liver transplantation
Eric M. Wu, Linda L. Wong, Brenda Y. Hernandez, Jun-Fang Ji, Wei Jia, Sandi A. Kwee, Sumodh
Kalathil
Hepatoma Res 2018;4:66 http://dx.doi.org/10.20517/2394-5079.2018.87
67 Endolymphatic immunotherapy for advanced hepatocellular carcinoma: an update of our
experience
Marialuisa Lugaresi, Yuval Katz, Riccardo Bertelli, Noa Ruhrman, Lorenza Puviani, Giuseppe
Cavallari, Caterina De Vinci, Giancarlo Pizza, Bruno Nardo
Hepatoma Res 2018;4:67 http://dx.doi.org/10.20517/2394-5079.2018.88